Skip to main content

Welkom bij THIM Hogeschool voor Fysiotherapie & Bohn Stafleu van Loghum

THIM Hogeschool voor Fysiotherapie heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL. Heb je een vraag, neem dan contact op met helpdesk@thim.nl.

Registreer

Om ook buiten de locaties van THIM, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van THIM.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

01-06-2007 | debate article

Periodical cardiovascular screening is mandatory for elite athletes

Pro screening

Auteurs: H. Inklaar, N. M. Panhuyzen-Goedkoop

Gepubliceerd in: Netherlands Heart Journal | Uitgave 6/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Sudden cardiac death (SCD) of an athlete is a very tragic event. When it concerns a well-known elite sportsman, it creates much publicity. Inevitably questions are raised about the health-promoting value of sports and the necessity of a mandatory periodical cardiovascular screening to prevent sports-related cardiac events. In order to answer the final question many aspects of SCD and screening in general have to be addressed.
Literatuur
go back to reference 26th Bethesda Conference. Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Am J Coll Cardiol 1994;24:845-99 and Med Sci Sports Exerc 1994;26:S223-S283. 26th Bethesda Conference. Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Am J Coll Cardiol 1994;24:845-99 and Med Sci Sports Exerc 1994;26:S223-S283.
go back to reference Whithby LG. Screening for disease, Definitions and criteria. Lancet 1974;333:819-21. Whithby LG. Screening for disease, Definitions and criteria. Lancet 1974;333:819-21.
go back to reference Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998;32:1881-4. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998;32:1881-4.
go back to reference Bille K, Figueiras D, Schamash P, Kappenberger, Brenner JI, Meijboom FJ, et al. Sudden cardiac death in athletes: the Lausanne Recommendations. Eur J Cardiovasc Prev Rehab 2006;13:1-17. Bille K, Figueiras D, Schamash P, Kappenberger, Brenner JI, Meijboom FJ, et al. Sudden cardiac death in athletes: the Lausanne Recommendations. Eur J Cardiovasc Prev Rehab 2006;13:1-17.
go back to reference Corrado D, Pellicia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26:16-24. Corrado D, Pellicia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26:16-24.
go back to reference Dolmans AJ, Pool J, Erdman-Trip JF, Smit B, Lubsen J. Het risico van overlijden bij sport. Ned Tijdschr Geneeskd 1984;128:595-8. Dolmans AJ, Pool J, Erdman-Trip JF, Smit B, Lubsen J. Het risico van overlijden bij sport. Ned Tijdschr Geneeskd 1984;128:595-8.
go back to reference Deligiannis A, Bjornstad H, Carre F, Heidbuchel H, Kouidi E, Panhuyzen-Goedkoop NM, et al. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehab 2006;13:687-94. Deligiannis A, Bjornstad H, Carre F, Heidbuchel H, Kouidi E, Panhuyzen-Goedkoop NM, et al. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehab 2006;13:687-94.
go back to reference Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the sudden death committee (clinical cardiology) and congenital cardiac defects committee (cardiovascular disease in young), American Heart Association. Circulation 1996;94:850-6. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the sudden death committee (clinical cardiology) and congenital cardiac defects committee (cardiovascular disease in young), American Heart Association. Circulation 1996;94:850-6.
go back to reference Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program. JAMA 2006;296:1593-601. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program. JAMA 2006;296:1593-601.
go back to reference Corrado D, Basso C, Schiavon, Thiene G. Identification of athletes with hypertrophic cardiomyopathy at risk of sudden death: cost-effectiveness analysis of screening strategies. Circulation 2002;106 (abstract): II-701. Corrado D, Basso C, Schiavon, Thiene G. Identification of athletes with hypertrophic cardiomyopathy at risk of sudden death: cost-effectiveness analysis of screening strategies. Circulation 2002;106 (abstract): II-701.
go back to reference Elliott P, Mckenna WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881-91. Elliott P, Mckenna WJ. Hypertrophic cardiomyopathy. Lancet 2004;363:1881-91.
go back to reference Maron BJ, Carney KP, Lever HM, Lewis JF, Barac I, Casey SA, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41:974-80. Maron BJ, Carney KP, Lever HM, Lewis JF, Barac I, Casey SA, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41:974-80.
go back to reference Corrado D, Pellicia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26: 516-24. Corrado D, Pellicia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26: 516-24.
go back to reference Gezondheidsraad. Jaarbericht bevolkingsonderzoek Den Haag: Gezondheidsraad, 2006; publicatie nr 2006/10. Gezondheidsraad. Jaarbericht bevolkingsonderzoek Den Haag: Gezondheidsraad, 2006; publicatie nr 2006/10.
go back to reference Panhuyzen-Goedkoop NM, Pluim BM, Senden PJ, Hoogsteen J, Bennekers H, Inklaar H, et al. Preventie van plotse dood in de sport bij jonge atleten in Nederland (consensusdocument). Geneesk en Sport 2005;38:107-12. Panhuyzen-Goedkoop NM, Pluim BM, Senden PJ, Hoogsteen J, Bennekers H, Inklaar H, et al. Preventie van plotse dood in de sport bij jonge atleten in Nederland (consensusdocument). Geneesk en Sport 2005;38:107-12.
go back to reference Tanaka Y, Yoshinaga M, Anan R, Tanaka Y, Nomura Y, Oku S, et al. Usefulness and cost effectiveness of cardiovascular screening of young athletes. Med Sci Sports Exerc 2006;38:2-6. Tanaka Y, Yoshinaga M, Anan R, Tanaka Y, Nomura Y, Oku S, et al. Usefulness and cost effectiveness of cardiovascular screening of young athletes. Med Sci Sports Exerc 2006;38:2-6.
go back to reference Tan HL, Hofmans N, Langen van IM, Wal van der AC, Wilde AA. Sudden unexplained death: Heritability and Diagnostic Yield of Cardiological and Genetic Examination in Surviving Relatives. Circulation 2005;112:207-13. Tan HL, Hofmans N, Langen van IM, Wal van der AC, Wilde AA. Sudden unexplained death: Heritability and Diagnostic Yield of Cardiological and Genetic Examination in Surviving Relatives. Circulation 2005;112:207-13.
go back to reference Pellicia A, Maron BJ, Culasso F, Di Paolo FM, Spataro A, Biffi A, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-84. Pellicia A, Maron BJ, Culasso F, Di Paolo FM, Spataro A, Biffi A, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-84.
Metagegevens
Titel
Periodical cardiovascular screening is mandatory for elite athletes
Pro screening
Auteurs
H. Inklaar
N. M. Panhuyzen-Goedkoop
Publicatiedatum
01-06-2007
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 6/2007
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03085984